Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Balchem (BCPC) Research & Development (2016 - 2025)

Balchem (BCPC) has disclosed Research & Development for 16 consecutive years, with $5.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Research & Development rose 12.02% to $5.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $18.5 million, a 10.22% increase, with the full-year FY2025 number at $18.5 million, up 10.22% from a year prior.
  • Research & Development was $5.1 million for Q4 2025 at Balchem, up from $4.5 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $5.1 million in Q4 2025 to a low of $2.7 million in Q1 2021.
  • A 5-year average of $3.8 million and a median of $3.9 million in 2023 define the central range for Research & Development.
  • Peak YoY movement for Research & Development: surged 99.07% in 2021, then crashed 35.55% in 2022.
  • Balchem's Research & Development stood at $4.7 million in 2021, then tumbled by 35.55% to $3.0 million in 2022, then increased by 29.39% to $3.9 million in 2023, then grew by 14.58% to $4.5 million in 2024, then rose by 12.02% to $5.1 million in 2025.
  • Per Business Quant, the three most recent readings for BCPC's Research & Development are $5.1 million (Q4 2025), $4.5 million (Q3 2025), and $4.3 million (Q2 2025).